MediBeacon® Transdermal GFR System receives device approval in China

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. BILL
4. MRK
5. MRNA
6. ADI
7. LOW
8. TJX
9. DE
10. COTY

Go back to MediBeacon® Transdermal GFR System receives device approval in China
(NYSE: VATE) Delayed: 7.94 +0.13 (1.66%)
Previous Close $7.81    52 Week High $ 
Open $7.78    52 Week Low $ 
Day High $8.00    P/E N/A 
Day Low $7.73    EPS $ 
Volume 9,365